Oculus Innovative Sciences Inc. (NASDAQ:OCLS) announced its quarterly earnings results on Thursday. The company reported ($0.61) earnings per share for the quarter.
Oculus Innovative Sciences (NASDAQ:OCLS) traded up 0.64% during mid-day trading on Thursday, reaching $4.74. The company had a trading volume of 171,863 shares. The stock’s 50-day moving average is $4.46 and its 200 day moving average is $4.87. Oculus Innovative Sciences has a 12 month low of $3.62 and a 12 month high of $9.65. The firm’s market capitalization is $19.91 million.
Separately, Maxim Group restated a “buy” rating and issued a $3.00 price target on shares of Oculus Innovative Sciences in a research report on Wednesday, April 20th.
Oculus Innovative Sciences, Inc is a specialty device and pharmaceutical company. The Company develops and markets solutions for the treatment of dermatological conditions and advanced tissue care in both humans and animals. The Company offers wound care products which are sold into the human and animal healthcare markets in the United States, Mexico and Europe.
